Amphastar Pharmaceuticals
AMPH
95 hedge funds and large institutions have $213M invested in Amphastar Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 47 increasing their positions, 26 reducing their positions, and 8 closing their positions.
4,825% more call options, than puts
Call options by funds: $197K | Put options by funds: $4K
81% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 26
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
33% more capital invested
Capital invested by funds: $160M → $213M (+$52.3M)
3% more funds holding
Funds holding: 92 → 95 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Teachers Advisors
New York
|
+$4.17M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.78M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.09M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.62M |
| 5 |
JP Morgan Chase
New York
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
-$3.57M |
| 2 |
BC
Broadfin Capital
New York
|
-$3.3M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.62M |
| 4 |
Renaissance Technologies
New York
|
-$1.53M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.41M |
AMPH Hedge Fund Activity: Q4 2015 in Review
95 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2015, worth a combined $213M — up 33% from $160M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AMPH positions and 8 closed out — a net gain of 3 holders — while 47 added to existing stakes and 26 trimmed.
The largest buyer was Teachers Advisors, adding an estimated $4.17M. The largest seller was UBS AM, cutting an estimated $3.57M.
- 95 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2015, up from 92 in Q3 2015.
- Funds reported $213M of Amphastar Pharmaceuticals stock for Q4 2015, up 33% quarter-over-quarter.
- 11 funds opened new Amphastar Pharmaceuticals positions in Q4 2015 and 8 closed out, a net change of +3 holders.
- The largest Amphastar Pharmaceuticals buyer in Q4 2015 was Teachers Advisors, an estimated $4.17M added.
- The largest Amphastar Pharmaceuticals seller in Q4 2015 was UBS AM, an estimated $3.57M sold.
Based on aggregated 13F filings for Q4 2015.